China Reviving World War II Airfield in America's Backyard
The project, launched on the atoll of Woleai in the Federated States of Micronesia, is approximately 400 miles south of Guam, a U.S. territory and military hub considered key to Washington's ability to project power in the Asia-Pacific.
Micronesia is one of the South Pacific's Freely Associated States—along with Palau and the Marshall Islands—whose defense and broader stability is guaranteed by Washington. But with the U.S. prioritizing funding elsewhere, China has made inroads in this region through infrastructure projects.
The islands lie along the so-called Second Island Chain, a string of islands Washington has long viewed as strategically important to containing a rising China in the event of a wartime scenario.
Western analysts have raised concerns that this activity could eke away at the U.S. military's position in the Pacific, given Beijing's policy of military-civil fusion that enables the People's Liberation Army to co-opt these dual-use facilities.
Newsweek has reached out to the U.S. State Department and Chinese Embassy in Micronesia with written requests for comment.
The Woleai runway was built by Imperial Japanese forces during World War II, but has long fallen into disrepair due to lack of funding.
The project was launched with fanfare Monday in a joint effort by China's Shandong Hengyue Municipal Engineering and Micronesia's Department of Transportation. Micronesian President Wesley Simina traveled in person to attend the ceremony.
The airfield will be a major boon to locals, who currently rely on dayslong boat trips to reach the nearest airstrip. It's also expected to support health care, business development, and education in the region.
Cleo Paskal, a non-resident senior fellow at the neoconservative think tank Foundation for Defense of Democracies, said that while $2 billion has been invested in Micronesia's Yap State, outer islands like Woleai have been neglected.
"Getting to the groundbreaking of the Woleai runway reconstruction was only possible by traveling for four days on a transport ship from Yap—a ship provided by China aid. The president arrived on a patrol boat provided by Australia. The U.S. was nowhere to be seen," Paskal wrote in a social media post.
"Tomorrow is Woleai's high school graduation. Don't expect to see any U.S. government representatives there either," she wrote. "The Chinese will be there though. Showing up is (more than) half the battle."
Domingo I-Kwei Yang, assistant research fellow at Taiwan's Institute for National Defense and Security Research, wrote in a recent report: "China aims to establish a Southern Link, connecting Asia and South America via Pacific strategic infrastructure hubs. Control over Pacific ports, airstrips, and ICT systems could serve dual-use purposes, enabling transit, logistics, and expanded influence in the U.S. backyard."
The Pentagon said in its 2024 report on Military and Security Developments Involving the People's Republic of China [PRC]: "Since 2015, the PRC has probably viewed engagement and deliberate corruption in the Pacific Island countries as an opportunity to expand its regional influence, press countries to switch diplomatic recognition from Taipei to Beijing, increase influence with regional security forces, and advance the PRC's responsible great power narrative."
Elsewhere in the Pacific, the U.S. military is reclaiming another World War II-era airfield on the island of Tinian in the Northern Mariana Islands, part of efforts to bolster the Second Island Chain as its Chinese rival closes the power gap.
Related Articles
Satellite Photos Show British Aircraft Carrier Heading Toward PacificChina Denies Ukraine's Russia Weapons ClaimPhotos Show New US Missiles Sent to China's DoorstepChina Warns US Ally Over Plan To Take Back Strategic Port
2025 NEWSWEEK DIGITAL LLC.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Los Angeles Times
an hour ago
- Los Angeles Times
Valadao supports Trump megabill set to disrupt healthcare for many of his constituents
Already a ripe target for Democrats in the next election, Central Valley Rep. David Valadao put his political future in deeper peril this week by voting in favor of legislation that slashes the Medicaid coverage essential to roughly two-thirds of his Republican dairy farmer from Hanford said that despite his concerns about President Trump's megabill, he voted to support it because of concessions he helped negotiate that will help his district, such as an additional $25 billion for rural hospitals, $1 billion for Western water infrastructure and agricultural preserving tax breaks benefiting the wealthy, the bill passed by narrow Republican majorities in both the House and Senate would reduce federal Medicaid spending by $1.04 trillion over 10 years, according to the nonpartisan Congressional Budget Office.


Business Insider
2 hours ago
- Business Insider
What Triggered the Wild 120% Rally in Regencell Bioscience Stock (RGC)?
Regencell Bioscience (RGC) stunned the market with a jaw-dropping 120% surge in a single trading session on Thursday, despite no major news. The company has a history of wild stock swings fueled by low float, insider control, and retail trading momentum. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. What Does Regencell Bioscience Do? Regencell focuses on developing traditional Chinese herbal therapies aimed at treating conditions like ADHD and autism. The company has no approved products, no revenue, no patents, and no distribution channels—its herbal treatments remain in the early stages of clinical testing. What's Happening with RGC Stock? RGC stock snapped a 10-day losing streak on Thursday with a 120% gain. The shares have skyrocketed by more than 17,000% year-to-date. On June 16, Regencell's stock surged around 300%, reaching an all-time high following a 38-for-1 stock split. The company said the split aimed to improve market liquidity and make its shares more affordable and accessible to investors. However, it has been trading down by over 70% from its peak in June. The company recently pointed out that short sellers are behind the recent rally and suggested a possible short squeeze. However, experts doubt this claim, pointing to data showing low short interest and modest trading volumes. For context, a short squeeze happens when a stock's price jumps quickly, and traders who had bet against it are forced to buy shares to limit their losses, driving the price up even more. Regencell's Financial Performance Regencell has posted net losses for six straight years. On June 30, 2025, the company shared its unaudited results for the six months ended December 31, 2024. It reported a net loss of $1.85 million, slightly better than the $2.19 million loss in the same period the year before. The update also showed lower operating costs and a small rise in total assets, suggesting a modest improvement in its financial position. Is RGC a Good Stock to Buy? RGC may be a risky bet, but its recent stock split makes it an appealing option for bold investors. The stock split lowered the share price, attracting more retail traders and driving strong buying interest, especially during price dips. With few shares available, any good news like success in a clinical trial could trigger another sharp price jump. While the stock may seem overvalued now, the traditional Chinese medicine (TCM) market is expected to grow significantly in the coming years. If Regencell's therapies prove effective, they could potentially sell at premium prices. On the flip side, even in the best-case scenario, companies in this space face tough regulatory barriers in Western markets, where herbal treatments must meet strict approval standards. With limited clinical evidence to back its claims, Regencell could face a difficult path forward.


Business Insider
2 hours ago
- Business Insider
BYD (BYDDF) Kicks Off EV Production at the New Brazil Plant
Chinese electric vehicle giant BYD (BYDDF) has officially kicked off production at its new Camaçari plant in Brazil. This facility, located in Bahia, marks a major milestone in its global expansion strategy. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. The plant that was built in just 15 months, rolled out its first model, the Dolphin Mini, which has become Brazil's best-selling EV with over 34,000 units sold to date. BYD plans to add a compact crossover SUV, Song Pro, and a compact sedan, King, to the production lineup in the coming weeks. With a $1 billion investment and an annual capacity of 150,000 vehicles, the facility uses smart systems to adjust production based on demand. BYD says the plant will support 20,000 jobs, both directly and through its local supply chain. BYD's Global Expansion Strategy This expansion comes as BYD continues its robust global growth. The company reported a 33% increase in global sales, reaching 2.1 million vehicles in the first half of 2025, with 464,000 units sold outside of China. Further, BYD's expansion into Brazil's EV market is a strategic move, as the country's NEV sales have surged 39% in the first five months of 2025. Apart from Brazil, the company has launched or announced facilities in Thailand, Hungary, and Turkey, part of a strategy to localize manufacturing and bypass rising tariffs in key markets. Importantly, BYD aims to sell 10 million vehicles annually by 2030, with 50% of sales coming from outside China, targeting regions like Europe and Latin America where EV demand is surging. Is BYDDF a Good Stock to Buy Now? Turning to Wall Street, analysts have a Strong Buy consensus rating on BYDDF stock based on 10 Buys assigned in the past three months. Furthermore, the average BYD stock price target of $22.89 per share implies 46.43% upside potential.